Search results - found 3
Biosimilar litigation and its impact on IP strategy (Market intelligence)
To succeed, developers of biosimilars must be able to demonstrate to the regulatory authorities a high degree of structural and functional similarity between their product and the approved originator product. They must further convince the authorities that the biosimilar manufacturing process is well understood, controlled and robust. Another challenge for biosimilar developers is to manufacture their product at a lower cost than the originators.
The patent litigation environment in India (Market intelligence)
Since 2005 the Indian courts have witnessed a sudden spurt of patent litigation, which was an obvious consequence of putting a product patents regime for pharmaceuticals and agrochemicals in place. These patent litigations originating from India have drawn global attention. But in recent years there has been a patent litigation shift from the field of pharmaceuticals to the fields of electronics and information and communications technology.
The pitfalls of compulsory licensing in India (Market intelligence)
Compulsory licences can mitigate the impact of exclusive rights. However, the compulsory licensing provisions must be used sparingly to avoid stifling innovation
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email